Heron Therapeutics's total assets for Q1 2025 were $235.75M, an increase of 1.12% from the previous quarter. HRTX total liabilities were $264.20M for the fiscal quarter, a -0.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.